Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 1
1965 1
1966 1
1968 1
1979 2
1980 2
1981 1
1982 3
1983 4
1984 3
1985 1
1986 3
1987 2
1988 7
1989 6
1990 3
1991 5
1992 4
1993 7
1994 2
1995 3
1996 2
1997 1
1998 10
1999 8
2000 3
2001 4
2002 8
2003 7
2004 11
2005 5
2006 12
2007 10
2008 17
2009 9
2010 12
2011 12
2012 6
2013 5
2014 7
2015 14
2016 15
2017 26
2018 25
2019 33
2020 35
2021 32
2022 25
2023 18
2024 30
2025 26

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

438 results

Results by year

Filters applied: . Clear all
Page 1
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2-3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study.
Singh S, Halperin D, Myrehaug S, Herrmann K, Pavel M, Kunz PL, Chasen B, Tafuto S, Lastoria S, Capdevila J, García-Burillo A, Oh DY, Yoo C, Halfdanarson TR, Falk S, Folitar I, Zhang Y, Aimone P, de Herder WW, Ferone D; all the NETTER-2 Trial Investigators. Singh S, et al. Among authors: halperin d. Lancet. 2024 Jun 29;403(10446):2807-2817. doi: 10.1016/S0140-6736(24)00701-3. Epub 2024 Jun 5. Lancet. 2024. PMID: 38851203 Clinical Trial.
Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Shah MH, Goldner WS, Benson AB, Bergsland E, Blaszkowsky LS, Brock P, Chan J, Das S, Dickson PV, Fanta P, Giordano T, Halfdanarson TR, Halperin D, He J, Heaney A, Heslin MJ, Kandeel F, Kardan A, Khan SA, Kuvshinoff BW, Lieu C, Miller K, Pillarisetty VG, Reidy D, Salgado SA, Shaheen S, Soares HP, Soulen MC, Strosberg JR, Sussman CR, Trikalinos NA, Uboha NA, Vijayvergia N, Wong T, Lynn B, Hochstetler C. Shah MH, et al. Among authors: halperin d. J Natl Compr Canc Netw. 2021 Jul 28;19(7):839-868. doi: 10.6004/jnccn.2021.0032. J Natl Compr Canc Netw. 2021. PMID: 34340212
Multiple endocrine neoplasia type 1 (MEN1): recommendations and guidelines for best practice.
Brandi ML, Pieterman CRC, English KA, Lines KE, Shariq OA, Marini F, Cuny T, Lewis MA, Stratakis CA, Perrier ND, Waguespack SG, Castinetti F, Valk GD, Thakker RV; Delphi Expert Panel. Brandi ML, et al. Lancet Diabetes Endocrinol. 2025 Aug;13(8):699-721. doi: 10.1016/S2213-8587(25)00119-6. Epub 2025 Jun 13. Lancet Diabetes Endocrinol. 2025. PMID: 40523372 Review.
International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin Lymphoma.
Binkley MS, Flerlage JE, Savage KJ, Akhtar S, Steiner R, Zhang XY, Dickinson M, Prica A, Major A, Hendrickson PG, Hopkins D, Ng A, Casulo C, Baron J, Roberts KB, Al Kendi J, Balogh A, Ricardi U, Torka P, Specht L, De Silva R, Pickard K, Blazin LJ, Henry M, Smith CM, Halperin D, Brady J, Brennan B, Senchenko MA, Reeves M, Hoppe BS, Terezakis S, Talaulikar D, Picardi M, Kirova Y, Fergusson P, Hawkes EA, Lee D, Doo NW, Barraclough A, Cheah CY, Ku M, Hamad N, Mutsando H, Gilbertson M, Marconi T, Viiala N, Maurer MJ, Eichenauer DA, Hoppe RT; GLOW Consortium. Binkley MS, et al. Among authors: halperin d. J Clin Oncol. 2024 Jul 1;42(19):2271-2280. doi: 10.1200/JCO.23.01655. Epub 2024 Mar 26. J Clin Oncol. 2024. PMID: 38531001
Delta-like ligand 3 (DLL3) landscape in pulmonary and extra-pulmonary neuroendocrine neoplasms.
Serrano AG, Rocha P, Freitas Lima C, Stewart A, Zhang B, Diao L, Fujimoto J, Cardnell RJ, Lu W, Khan K, Sable B, Ellison AR, Wistuba II, Concannon KF, Halperin DM, Bogdan C, Sircar K, Zhang M, Cargill K, Wang Q, Aparicio A, Lazar A, Hernandez S, Estrella J, Ramalingam P, El-Naggar A, Kalhor N, Gay CM, Byers LA, Solis Soto LM. Serrano AG, et al. Among authors: halperin dm. NPJ Precis Oncol. 2024 Nov 19;8(1):268. doi: 10.1038/s41698-024-00739-y. NPJ Precis Oncol. 2024. PMID: 39558076 Free PMC article.
Bronchiolitis obliterans--current concepts.
Ezri T, Kunichezky S, Eliraz A, Soroker D, Halperin D, Schattner A. Ezri T, et al. Among authors: halperin d. Q J Med. 1994 Jan;87(1):1-10. doi: 10.1093/oxfordjournals.qjmed.a068855. Q J Med. 1994. PMID: 8140211 Free PMC article. Review.
Epidemiology of Neuroendocrine Neoplasms in the US.
Dasari A, Wallace K, Halperin DM, Maxwell J, Kunz P, Singh S, Chasen B, Yao JC. Dasari A, et al. Among authors: halperin dm. JAMA Netw Open. 2025 Jun 2;8(6):e2515798. doi: 10.1001/jamanetworkopen.2025.15798. JAMA Netw Open. 2025. PMID: 40553474 Free PMC article.
Molecular, Socioeconomic, and Clinical Factors Affecting Racial and Ethnic Disparities in Colorectal Cancer Survival.
Yousef M, Yousef A, Chowdhury S, Fanaeian MM, Knafl M, Peterson J, Zeineddine M, Alfaro K, Zeineddine F, Goldstein D, Hornstein N, Dasari A, Huey R, Johnson B, Higbie V, Bent A, Kee B, Lee M, Morelli MP, Morris VK, Halperin D, Overman MJ, Parseghian C, Vilar E, Wolff R, Raghav KP, White MG, Uppal A, Sun R, Wang W, Kopetz S, Willis J, Shen JP. Yousef M, et al. Among authors: halperin d. JAMA Oncol. 2024 Nov 1;10(11):1519-1529. doi: 10.1001/jamaoncol.2024.3666. JAMA Oncol. 2024. PMID: 39264607 Free PMC article.
438 results